FDA has approved Takedas Livtencity as the first approved treatment for adults and pediatric patients with post-transplant cytomegalovirus infection t...
FDA approves an Aadi Bioscience NDA for Fyarro (sirolimus protein-bound particles for injectable suspension) for treating adult patients with locally ...
Pfizer asks a California federal court for an injunction against an ex-employee it says took confidential information and trade secrets.
FDA places a partial clinical hold a Kura Oncology Phase 1b study (KOMET-001) of KO-539 in patients with relapsed or refractory acute myeloid leukemia...
Federal Register notice: FDA issues an order permanently debarring Maytee Lledo from providing services in any capacity to a person that has an approv...
Federal Register notice: FDA classifies the general laparoscopic power morcellation containment system into Class 2 (special controls).
Sagent Pharmaceuticals recalls four lots of levetiracetam injection due to container closure integrity concerns.
The Sedgwick Recall Index for the third quarter shows that both medical device and drug recalls surged.